IceCure Medical (NASDAQ:ICCM – Get Free Report) and Biocorrx (OTCMKTS:BICX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.
Risk and Volatility
IceCure Medical has a beta of 0.29, suggesting that its stock price is 71% less volatile than the S&P 500. Comparatively, Biocorrx has a beta of 0.33, suggesting that its stock price is 67% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and price targets for IceCure Medical and Biocorrx, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| IceCure Medical | 1 | 1 | 1 | 0 | 2.00 |
| Biocorrx | 0 | 1 | 0 | 0 | 2.00 |
Institutional and Insider Ownership
0.6% of IceCure Medical shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 21.4% of Biocorrx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares IceCure Medical and Biocorrx’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| IceCure Medical | -445.61% | -221.04% | -118.89% |
| Biocorrx | N/A | N/A | -96.39% |
Valuation and Earnings
This table compares IceCure Medical and Biocorrx”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| IceCure Medical | $3.38 million | 8.44 | -$15.06 million | ($0.24) | -1.63 |
| Biocorrx | $10,000.00 | 1,056.00 | -$5.11 million | ($0.32) | -1.25 |
Biocorrx has lower revenue, but higher earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Biocorrx, indicating that it is currently the more affordable of the two stocks.
Summary
Biocorrx beats IceCure Medical on 8 of the 13 factors compared between the two stocks.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
About Biocorrx
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.
